Secondary Logo

Journal Logo

August 1, 2019 - Volume 33 - Issue 10
pp: 1545-1681


Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen

Rizzardini, Giuliano; Gori, Andrea; Miralles, Celia; More

AIDS. 33(10):1583-1593, August 1, 2019.

Hyperglycemia and insulin function in antiretroviral treatment-naive HIV patients in Ethiopia: a potential new entity of diabetes in HIV?

Faurholt-Jepsen, Daniel; Olsen, Mette F.; Andersen, Anna B.; More

AIDS. 33(10):1595-1602, August 1, 2019.

CONCISE COMMUNICATIONS


E157Q integrase strand-transfer inhibitor substitution in patients with acute/recent HIV infection

Ambrosioni, Juan; Rico, José Ángel Fernández-Caballero; Nicolás, David; More

AIDS. 33(10):1613-1617, August 1, 2019.

Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study

Palanee-Phillips, Thesla; Brown, Elizabeth R.; Szydlo, Daniel; More

AIDS. 33(10):1619-1622, August 1, 2019.


Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure

Shroufi, Amir; Van Cutsem, Gilles; Cambiano, Valentina; More

AIDS. 33(10):1635-1644, August 1, 2019.

Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy

Pantazis, Nikos; Papastamopoulos, Vasilios; Paparizos, Vasilios; More

AIDS. 33(10):1645-1655, August 1, 2019.

CONCISE COMMUNICATIONS


Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women

Murnane, Pamela M.; Bacchetti, Peter; Currier, Judith S.; More

AIDS. 33(10):1657-1662, August 1, 2019.